New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection. [electronic resource]
- The Journal of biological chemistry Feb 2011
- 4978-90 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1083-351X
10.1074/jbc.M110.168955 doi
Allosteric Regulation--drug effects Chemokine CCL3--metabolism Cyclohexanes--pharmacology Guanosine Triphosphate--analogs & derivatives HEK293 Cells HIV Envelope Protein gp120--antagonists & inhibitors HIV Infections--drug therapy HIV-1--metabolism Humans Ligands Maraviroc Protein Binding--drug effects Receptors, CCR5--agonists Triazoles--pharmacology